Literature DB >> 9875145

Double intratracheal instillation of keratinocyte growth factor prevents bleomycin-induced lung fibrosis in rats.

K Sugahara1, K Iyama, M J Kuroda, K Sano.   

Abstract

Alveolar re-epithelialization is necessary in the repair of damaged alveolar epithelium after lung injury. Keratinocyte growth factor (KGF) has been shown to be a potent proliferation and differentiation factor for rat alveolar type II cells. The present study examined whether KGF would prevent bleomycin-induced lung fibrosis. Adult rats were anaesthetized and recombinant human KGF (rhKGF) (150 micrograms/kg) or saline was injected intratracheally at 48 h before and 24 h after bleomycin (Bleo, 5 mg/kg) instillation. Seven and 14 days after the last administration, rat lungs were processed for lung physiology, immunohistochemistry, and in situ hybridization. Double instillation of KGF prevented the loss of body weight and reduction in total lung capacity (TLC) due to Bleo, and markedly attenuated the protein accumulation and mRNA expression of collagen types I and III and the decreased expression of surfactant protein mRNAs in the fibrotic lesions of Bleo-treated rats. KGF may play an important role in maintaining alveolar epithelium and repairing the damaged epithelium after lung injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875145     DOI: 10.1002/(SICI)1096-9896(199809)186:1<90::AID-PATH137>3.0.CO;2-X

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  28 in total

1.  Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.

Authors:  Jae W Lee; Xiaohui Fang; Naveen Gupta; Vladimir Serikov; Michael A Matthay
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

Review 2.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

3.  Fibroblast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin.

Authors:  Robert D Guzy; Ivan Stoilov; Timothy J Elton; Robert P Mecham; David M Ornitz
Journal:  Am J Respir Cell Mol Biol       Date:  2015-01       Impact factor: 6.914

4.  Attenuating endogenous Fgfr2b ligands during bleomycin-induced lung fibrosis does not compromise murine lung repair.

Authors:  BreAnne MacKenzie; Ingrid Henneke; Stefanie Hezel; Denise Al Alam; Elie El Agha; Cho-Ming Chao; Jennifer Quantius; Jochen Wilhelm; Matthew Jones; Kerstin Goth; Xiaokun Li; Werner Seeger; Melanie Königshoff; Susanne Herold; Albert A Rizvanov; Andreas Günther; Saverio Bellusci
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-03-27       Impact factor: 5.464

Review 5.  Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.

Authors:  David N O'Dwyer; Shanna L Ashley; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-29       Impact factor: 5.464

6.  Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria.

Authors:  Jae W Lee; Anna Krasnodembskaya; David H McKenna; Yuanlin Song; Jason Abbott; Michael A Matthay
Journal:  Am J Respir Crit Care Med       Date:  2013-04-01       Impact factor: 21.405

7.  Overexpression of fibroblast growth factor-10 during both inflammatory and fibrotic phases attenuates bleomycin-induced pulmonary fibrosis in mice.

Authors:  Varsha V Gupte; Suresh K Ramasamy; Raghava Reddy; Jooeun Lee; Paul H Weinreb; Shelia M Violette; Andreas Guenther; David Warburton; Barbara Driscoll; Parviz Minoo; Saverio Bellusci
Journal:  Am J Respir Crit Care Med       Date:  2009-06-04       Impact factor: 21.405

Review 8.  Potential application of mesenchymal stem cells in acute lung injury.

Authors:  Jae Woo Lee; Naveen Gupta; Vladimir Serikov; Michael A Matthay
Journal:  Expert Opin Biol Ther       Date:  2009-10       Impact factor: 4.388

Review 9.  Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment.

Authors:  Nasreen Khalil; Robert O'Connor
Journal:  CMAJ       Date:  2004-07-20       Impact factor: 8.262

10.  Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis.

Authors:  Susana Aguilar; Chris J Scotton; Katrina McNulty; Emma Nye; Gordon Stamp; Geoff Laurent; Dominique Bonnet; Sam M Janes
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.